PURPOSE: Retrospective analysis of the dilatation (PTRA) of renal arterial dysplastic stenosis (RADS). METHODS: Seventy patients suffering from hypertension (87 RADS) were treated at our institution for medial (83%) or non-classified fibrodysplasias (17%). Four patients suffered from renal insufficiency. Two endoprostheses were implanted. We evaluated blood pressure with the USCSRH criteria and renal insufficiency with the Martin criteria. RESULTS: Ninety-five percent technical success and 87.9% clinical success for blood pressure were obtained, with worse results for patients older than 57 years or with a history of hypertension greater than 9 years. Results were better when the RADS was responsible for an ipsilateral renal atrophy or for poorly controlled hypertension. No renal insufficiency worsened during the follow-up. CONCLUSION: PTRA is a first-line treatment for renovascular hypertension caused by RADS. The results were encouraging despite a high average age of the subjects and frequent associated extrarenal vascular lesions.
PURPOSE: Retrospective analysis of the dilatation (PTRA) of renal arterial dysplastic stenosis (RADS). METHODS: Seventy patients suffering from hypertension (87 RADS) were treated at our institution for medial (83%) or non-classified fibrodysplasias (17%). Four patients suffered from renal insufficiency. Two endoprostheses were implanted. We evaluated blood pressure with the USCSRH criteria and renal insufficiency with the Martin criteria. RESULTS: Ninety-five percent technical success and 87.9% clinical success for blood pressure were obtained, with worse results for patients older than 57 years or with a history of hypertension greater than 9 years. Results were better when the RADS was responsible for an ipsilateral renal atrophy or for poorly controlled hypertension. No renal insufficiency worsened during the follow-up. CONCLUSION: PTRA is a first-line treatment for renovascular hypertension caused by RADS. The results were encouraging despite a high average age of the subjects and frequent associated extrarenal vascular lesions.
Authors: Y K Yang; Y Zhang; X Meng; K Q Yang; X J Jiang; H Y Wu; H M Zhang; L Song; L P Wang; L G Gao; X L Zhou Journal: Clin Res Cardiol Date: 2016-06-06 Impact factor: 5.460